Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The patient (or their legal representative) must have signed and dated the required consent and privacy form.
- The person must be 18 years of age or older.
- The person must have a diagnosis of cervical cancer.
- The cancer must be either locally advanced (meaning surgery to cure is not suitable), or it has come back, or it has spread to other parts of the body.
- The person must have received some form of treatment for advanced cervical cancer between January 2018 and December 2021.
Who may not be able to join:
- People who are currently participating in another clinical trial involving medications for advanced cervical cancer.
- People who have previously participated in any clinical trial (confirm with trial site).
- People who have previously been given Pembrolizumab, Olaparib, or Levantinib, or any medications belonging to the same drug families as these.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +39 03626331
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The proportion of patients receiving each different treatment pattern of LA, recurrent, and metastatic CC (%); The proportion of patient with recurrence or dead after treatment and remission (%); Median time from remission to recurrence; Number of lines of treatment; The costs in terms of resources utilization associated to the different treatment patterns of LA, recurrent and metastatic CC
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.